Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.01 USD | +1.84% | +9.84% | +16.80% |
05-13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
05-10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SOLENO THERAPEUTICS, INC. | Bio Therapeutic Drugs | +1.84% | +9.84% | +16.80% | +871.28% | +55.92% | 1.68B |
Technical Rankings Surperformance
- Stock Market
- Equities
- SLNO Stock
- Charts Soleno Therapeutics, Inc.
- Comparison Chart